NM_000435.3:c.5816-8T>C

Variant names:

• chr19-15162570-A-G
• rs4809030
• NM_000435.3:c.5816-8T>C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_000435.3(NOTCH3):​c.5816-8T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.893 in 1,612,158 control chromosomes in the GnomAD database, including 644,165 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.90 (62118 hom., cov: 31)
  • Exomes 𝑓: 0.89 (582047 hom.)
• Consequence: NOTCH3 NM_000435.3 splice_region, intron
• Scores: Splicing: ADA: 0.000005957
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:11
• Conservation: PhyloP100: 0.364

Genes affected

NOTCH3 (HGNC:7883): (notch receptor 3) This gene encodes the third discovered human homologue of the Drosophilia melanogaster type I membrane protein notch. In Drosophilia, notch interaction with its cell-bound ligands (delta, serrate) establishes an intercellular signalling pathway that plays a key role in neural development. Homologues of the notch-ligands have also been identified in human, but precise interactions between these ligands and the human notch homologues remains to be determined. Mutations in NOTCH3 have been identified as the underlying cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Benign. Variant got -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.88).
• BP6: Variant 19-15162570-A-G is Benign according to our data. Variant chr19-15162570-A-G is described in ClinVar as [Benign]. Clinvar id is 256145.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-15162570-A-G is described in Lovd as [Benign].
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.966 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
NOTCH3	NM_000435.3	c.5816-8T>C		splice_region_variant, intron_variant	Intron 31 of 32	ENST00000263388.7	NP_000426.2
NOTCH3	XM_005259924.5	c.5660-8T>C		splice_region_variant, intron_variant	Intron 30 of 31		XP_005259981.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
NOTCH3	ENST00000263388.7	c.5816-8T>C		splice_region_variant, intron_variant	Intron 31 of 32	1	NM_000435.3	ENSP00000263388.1
NOTCH3	ENST00000597756.1	c.329-8T>C		splice_region_variant, intron_variant	Intron 2 of 2	2		ENSP00000468879.1
NOTCH3	ENST00000595514.1	n.*24-8T>C		splice_region_variant, intron_variant	Intron 3 of 4	3		ENSP00000470661.1

Frequencies

GnomAD3 genomes AF: 0.901 AC: 137041 AN: 152068 Hom.: 62067 Cov.: 31

Gnomad AFR AF: 0.974

Gnomad AMI AF: 0.885

Gnomad AMR AF: 0.781

Gnomad ASJ AF: 0.878

Gnomad EAS AF: 0.805

Gnomad SAS AF: 0.852

Gnomad FIN AF: 0.884

Gnomad MID AF: 0.886

Gnomad NFE AF: 0.899

Gnomad OTH AF: 0.878

GnomAD3 exomes AF: 0.864 AC: 216238 AN: 250336 Hom.: 94035 AF XY: 0.866 AC XY: 117190 AN XY: 135302

Gnomad AFR exome AF: 0.977

Gnomad AMR exome AF: 0.715

Gnomad ASJ exome AF: 0.872

Gnomad EAS exome AF: 0.800

Gnomad SAS exome AF: 0.855

Gnomad FIN exome AF: 0.887

Gnomad NFE exome AF: 0.900

Gnomad OTH exome AF: 0.862

GnomAD4 exome AF: 0.892 AC: 1302111 AN: 1459972 Hom.: 582047 Cov.: 34 AF XY: 0.891 AC XY: 646816 AN XY: 726344

Gnomad4 AFR exome AF: 0.979

Gnomad4 AMR exome AF: 0.722

Gnomad4 ASJ exome AF: 0.872

Gnomad4 EAS exome AF: 0.827

Gnomad4 SAS exome AF: 0.853

Gnomad4 FIN exome AF: 0.887

Gnomad4 NFE exome AF: 0.903

Gnomad4 OTH exome AF: 0.879

GnomAD4 genome AF: 0.901 AC: 137150 AN: 152186 Hom.: 62118 Cov.: 31 AF XY: 0.897 AC XY: 66714 AN XY: 74396

Gnomad4 AFR AF: 0.974

Gnomad4 AMR AF: 0.781

Gnomad4 ASJ AF: 0.878

Gnomad4 EAS AF: 0.806

Gnomad4 SAS AF: 0.851

Gnomad4 FIN AF: 0.884

Gnomad4 NFE AF: 0.899

Gnomad4 OTH AF: 0.879

Alfa AF: 0.905 Hom.: 26237

Bravo AF: 0.895

Asia WGS AF: 0.850 AC: 2956 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:11

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not specified Benign:4

-

Genome Diagnostics Laboratory, Amsterdam University Medical Center

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

-

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

-

PreventionGenetics, part of Exact Sciences

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

-

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center

Significance: Benign

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

not provided Benign:4

-

Breakthrough Genomics, Breakthrough Genomics

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: not provided

- -

Jan 14, 2021

ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Feb 04, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Sep 25, 2019

GeneDx

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Benign:2

Sep 05, 2021

Genome-Nilou Lab

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Jan 12, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Lateral meningocele syndrome Benign:1

Sep 05, 2021

Genome-Nilou Lab

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.88
CADD	Benign	2.3
DANN	Benign	0.59

Splicing

Name	Calibrated prediction	Score	Prediction
dbscSNV1_ADA	Benign	0.0000060
dbscSNV1_RF	Benign	0.0
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs4809030; hg19: chr19-15273381;